6,052 Shares in Zoetis Inc. $ZTS Acquired by Morningstar Investment Management LLC

Morningstar Investment Management LLC acquired a new position in shares of Zoetis Inc. (NYSE:ZTS) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 6,052 shares of the company’s stock, valued at approximately $944,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ZTS. Brighton Jones LLC raised its position in Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after purchasing an additional 2,978 shares during the period. Dynamic Advisor Solutions LLC purchased a new stake in Zoetis in the first quarter valued at $1,253,000. Ritholtz Wealth Management raised its position in Zoetis by 7.1% in the first quarter. Ritholtz Wealth Management now owns 21,062 shares of the company’s stock valued at $3,468,000 after purchasing an additional 1,400 shares during the period. Aries Wealth Management purchased a new stake in Zoetis in the first quarter valued at $226,000. Finally, Sound Income Strategies LLC raised its position in Zoetis by 141.4% in the first quarter. Sound Income Strategies LLC now owns 280 shares of the company’s stock valued at $46,000 after purchasing an additional 164 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Stifel Nicolaus downgraded Zoetis from a “buy” rating to a “hold” rating and reduced their target price for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Leerink Partnrs downgraded Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Argus reaffirmed a “buy” rating and issued a $190.00 price objective on shares of Zoetis in a research note on Tuesday, September 9th. Finally, Leerink Partners cut Zoetis from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $196.71.

Zoetis Trading Up 0.8%

Shares of NYSE ZTS opened at $142.29 on Tuesday. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $196.55. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The stock has a fifty day simple moving average of $149.04 and a 200-day simple moving average of $154.19. The stock has a market capitalization of $63.06 billion, a PE ratio of 24.49, a PEG ratio of 2.26 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the firm posted $1.56 earnings per share. The company’s revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s payout ratio is presently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.